logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
I

Ian D. Davis

university of western australia

76H指数
690论文数
2.9W被引数
收录论文 188
发表时间
logo
Re: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer局部晚期前列腺癌中的经皮雌二醇贴剂
errEuropean Urology
IF25.2
err2026-06-17
err0
PREAI
errIan D. Davis
err分享
err收藏
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial早期PSMA上调对恩扎卢胺±177Lu-PSMA-617治疗高危转移性去势抵抗性前列腺癌疗效的预测价值：随机II期ENZA-p试验的亚组研究
errNature Cancer
IF28.5
err2026-04-01
err0
PREAI
errEmmett, Louise; Swiha, Mina; Papa, Nathan; Subramaniam, Shalini; Crumbaker, Megan; Joshua, Anthony; Nguyen, Andrew; Weickhardt, Andrew; Lee, Sze-Ting; Ng, Siobhan; Francis, Roslyn; Goh, Jeffrey; Pattison, David; Pathmanandavel, Sarennya; Hope, Thomas; Ayati, Narjess; Hofman, Michael; Sandhu, Shahneen; Niu, Claire; Martin, Andrew; Thomas, Hayley; Stockler, Martin; Davis, Ian
err分享
err收藏
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)在接受基于免疫治疗的一线治疗后转移性肾细胞癌（mRCC）中的患者流失率：来自国际mRCC数据库联盟（IMDC）的结果
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
err分享
err收藏
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测
errNature Communications
IF15.7
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
err分享
err收藏
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024未来晚期前列腺癌临床研究的路线图：2024年晚期前列腺癌共识会议（APCCC）的研究结果
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
err分享
err收藏
Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomy基于肿瘤的表观遗传学特征作为根治性前列腺切除术后前列腺癌侵袭性的标志物
errBritish Journal of Cancer
IF6.8
err2025-11-20
err0
PREAI
errYiyue Zhu; Elaheh Zarean; Danmeng L. Li; Robert L. O’Reilly; Ian D. Davis; Renea A. Taylor; Arun A. Azad; Damien M. Bolton; Nathan Papa; Nathan Lawrentschuk; Robert J. MacInnis; Roger L. Milne; Graham G. Giles; Melissa C. Southey; Pierre-Antoine Dugué
err分享
err收藏
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer转移性激素敏感性前列腺癌早期多西他赛和恩扎卢amide目标试验模拟
errBJU International
IF4.4
err2025-11-05
err0
PREAI
errYu Yang Soon; Ian C. Marschner; I. Manjula Schou; Christopher J Sweeney; Ian D. Davis; Martin R. Stockler; Andrew J. Martin
err分享
err收藏
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis比较性生存分析：激素敏感性转移性前列腺癌按疾病体积和转移时间划分——一项动态网络Meta分析
errEuropean Urology
IF25.2
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
err分享
err收藏
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment在制定关于前列腺癌药物报销决策时，社会关注的关键因素：一项离散选择实验
errJNCI: Journal of the National Cancer Institute
IF0
err2025-11-03
err0
errOAAI
errRafael Emilio De Feria Cardet, PhD; Stephen Goodall, PhD; Tracey-Lea Laba, PhD; Marion Haas, PhD; Ian D Davis, PhD; Deborah J Street, PhD; Christopher J Sweeney, PhD; Richard De Abreu Lourenço, PhD
err分享
err收藏
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial基线PSMA-PET总肿瘤体积和SUVmean在转移性去势抵抗性前列腺癌中的预后和预测价值：一项来自多中心、开放标签、随机、II期试验ENZA-p (ANZUP1901)的亚研究
errlancet oncology
IF0
err2025-07-30
err0
PREAI
errLouise Emmett; Nathan Papa; Shalini Subramaniam; Megan Crumbaker; Andrew Nguyen; Anthony M Joshua; Shahneen Sandhu; Andrew Weickhardt; Sze-Ting Lee; Siobhan Ng; Roslyn J Francis; Jeffrey C Goh; David A Pattison; Thean Hsiang Tan; Ian D Kirkwood; Narjess Ayati; Claire Niu; Michael S Hofman; Andrew James Martin; Hayley Thomas; Ian D Davis; Martin R Stockler
err分享
err收藏
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective如何支持泌尿生殖和前列腺临床 trial 的参与者：一项定性研究视角
errPsycho-Oncology
IF3.5
err2025-07-14
err0
errOAAI
errNatasha A. Roberts; Ian D. Davis; David Wyld; Jeffrey Goh; Maxwell Thompson; Craig Gedye; Haryana M. Dhillon
err分享
err收藏
If the Treatment for Metastatic Hormone-sensitive Prostate Cancer Stops Working, What Next?如果转移性激素敏感性前列腺癌的治疗失效，接下来该怎么办？
errEuropean Urology
IF25.2
err2025-06-21
err0
PREAI
errIan D. Davis
err分享
err收藏
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)循环脂质面板PCPro与转移性激素敏感前列腺癌临床结局的关联：ENZAMET III期随机试验（ANZUP 1304）的事后分析
errAnnals of Oncology
IF65.4
err2025-05-20
err0
PREAI
errH.-M. Lin; T. Scheinberg; N. Portman; R.M.N. Kim; R. Mellor; K. Huynh; A.N. Faulkner; N.A. Mellett; I.D. Davis; A. Martin; D. Sullivan; A. Joshua; M. McJannett; V. Subhash; S. Yip; A.A. Azad; I.C. Marschner; S.A. North; R.S. McDermott; K.N. Chi; M.R. Stockler; C.J. Sweeney; P.J. Meikle; L.G. Horvath
err分享
err收藏
But Words Will Never Hurt Me但言语永远不会伤害我
errEUROPEAN UROLOGY
IF25.2
err2025-03-01
err0
PREAI
errDavis, Ian D.; Anton, Angelyn; Kwan, Edmond M.
err分享
err收藏
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial[TheraP研究]：转移性去势抵抗性前列腺癌患者接受[177Lu]Lu-PSMA-617与卡巴他赛治疗疗效反应的预后和预测模型的验证——一项来自随机、开放标签、Ⅱ期临床试验的事后分析
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2025-02-01
err3
errOAAI
errGafita, Andrei; Martin, Andrew J.; Emmett, Louise; Eiber, Matthias; Iravani, Amir; Fendler, Wolfgang P.; Buteau, James; Sandhu, Shahneen; Azad, Arun A.; Herrmann, Ken; Stockler, Martin R.; Davis, Ian D.; Hofman, Michael S.
err分享
err收藏
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer局部晚期和转移性激素敏感性前列腺癌的联合疗法
errEUROPEAN UROLOGY
IF25.2
err2025-02-01
err0
errOAAI
errAzad, Arun A.; Kostos, Louise; Agarwal, Neeraj; Attard, Gerhardt; Davis, Ian D.; Dorff, Tanya; Gillessen, Silke; Parker, Chris; Smith, Matthew R.; Sweeney, Christopher J.; Tombal, Bertrand; Fizazi, Karim
err分享
err收藏
Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studies转移性激素敏感型前列腺癌中的恩扎鲁胺: 拱门和ENZAMET随访研究的简明语言总结
errFUTURE ONCOLOGY
IF2.6
err2024-10-15
err0
errOAAI
errArmstrong, Andrew J.; Azad, Arun A.; Conduit, Ciara; Haas, Gabriel P.; Bland, Christopher; Davis, Ian D.
err分享
err收藏
Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance
errJOURNAL OF CLINICAL INVESTIGATION
IF13.6
err2024-09-17
err1
errOAAI
errSharifi, Nima; Diaz, Robert; Lin, Hui-Ming; Roberts, Evan; Horvath, Lisa G.; Martin, Andrew; Stockler, Martin R.; Yip, Sonia; Subhash, Vinod V.; Portman, Neil; Davis, Ian D.; Sweeney, Christopher J.
err分享
err收藏
Challenges of estimating treatment effects after a positive interim analysis
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err0
PREAI
errSoon, Yu Yang; Marschner, Ian C.; Schou, Manjula; Sweeney, Christopher J.; Davis, Ian D.; Stockler, Martin R.; Martin, Andrew J.
err分享
err收藏
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-06-01
err2
PREAI
errWeickhardt, Andrew; Foroudi, Farshad; Lawrentschuk, Nathan; Xie, Jing; Sidhom, Mark; Pal, Abhijit; Grimison, Peter; Zhang, Alison; Ng, Siobhan; Tang, Colin; Hovey, Elizabeth; Chen, Colin; Hruby, George; Guminski, Alexander; McJannett, Margaret; Conduit, Ciara; Tran, Ben; Davis, Ian D.; Hayne, Dickon
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Mark A. Rubin
H 指数: 186 · 论文数: 1.5K
H
Howard I. Scher
H 指数: 164 · 论文数: 1.4K
G
Graham G. Giles
H 指数: 164 · 论文数: 2.4K
J
Johann S. de Bono
H 指数: 160 · 论文数: 2.5K
L
Lloyd J. Old
H 指数: 155 · 论文数: 961
查看更多